{"altmetric_id":1671584,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["134779230009524"],"posts_count":2},"blogs":{"unique_users_count":2,"unique_users":[53324,52093],"posts_count":2},"news":{"unique_users_count":11,"unique_users":["ecancer","health_canal","medpage_today","reuters","science_daily","the_medical_news","medical_news_today","fox_news","herald_sun","eurekalert","medicalxpress"],"posts_count":12},"total":{"posts_count":41},"twitter":{"unique_users_count":23,"unique_users":["CancerCouncilOz","ArteSanoDeTi","40JennyWilliams","BCSC_research","rsm2800","EuropaDonnaIrel","rogersro","talkabouthealth","bettycjung","SGSmith_87","InOncology","cokelly","DrMisialek","PenrynPam","aftimosp","ASCO","BCCEU","CRWLibrary","PharmD_Onc","ugcfarmacg","intervalolibre","elizass9","TJH0828"],"posts_count":25}},"selected_quotes":["Cancer in 2nd breast less likely with #tamoxifen use for BRCA1\/2 carriers","Tamoxifen use is associated with a reduction in contralateral #BreastCancer risk for BRCA1 BRCA2 mutation carriers","Tamoxifen use associated with reduction of contralateral #BreastCancer in BRCA1 and BRCA2 @ASCO","Impt JCO study 8\/5\/13: Tamoxifen reduces the incidence of contralateral breast ca in BRCA carriers #bcsm"],"citation":{"abstract":"To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and\/or BRCA2 mutation carriers.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Kelly-Anne Phillips","Roger L. Milne","Matti A. Rookus","Mary B. Daly","Antonis C. Antoniou","Susan Peock","Debra Frost","Douglas F. Easton","Steve Ellis","Michael L. Friedlander","Saundra S. Buys","Nadine Andrieu","Catherine Nogu\u00e8s","Dominique Stoppa-Lyonnet","Val\u00e9rie Bonadona","Pascal Pujol","Sue Anne McLachlan","Esther M. John","Maartje J. Hooning","Caroline Seynaeve","Rob A.E.M. Tollenaar","David E. Goldgar","Mary Beth Terry","Trinidad Caldes","Prue C. Weideman","Irene L. Andrulis","Christian F. Singer","Kate Birch","Jacques Simard","Melissa C. Southey","H\u00e5kan L. Olsson","Anna Jakubowska","Edith Olah","Anne-Marie Gerdes","Lenka Foretova","John L. Hopper","Phillips KA","Milne RL","Rookus MA","Daly MB","Antoniou AC","Peock S","Frost D","Easton DF","Ellis S","Friedlander ML","Buys SS","Andrieu N","Nogu\u00e8s C","Stoppa-Lyonnet D","Bonadona V","Pujol P","McLachlan SA","John EM","Hooning MJ","Seynaeve C","Tollenaar RA","Goldgar DE","Terry MB","Caldes T","Weideman PC","Andrulis IL","Singer CF","Birch K","Simard J","Southey MC","Olsson HL","Jakubowska A","Olah E","Gerdes AM","Foretova L","Hopper JL"],"doi":"10.1200\/jco.2012.47.8313","first_seen_on":"2013-08-06T06:59:26+00:00","funders":["cruk","nci"],"handles":[],"isbns":[],"issns":["1527-7755","0732-183X"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1378832635,"links":["http:\/\/jco.ascopubs.org\/content\/early\/2013\/08\/05\/JCO.2012.47.8313.short?rss=1","http:\/\/jco.ascopubs.org\/content\/early\/2013\/08\/05\/JCO.2012.47.8313.abstract?sid=bc147bd5-5f0d-44d4-afa7-a1409d32908b","http:\/\/jco.ascopubs.org\/content\/early\/2013\/08\/05\/JCO.2012.47.8313","http:\/\/jco.ascopubs.org\/content\/early\/2013\/08\/05\/JCO.2012.47.8313.abstract","http:\/\/jco.ascopubs.org\/content\/31\/25\/3091?cmpid=jco_etoc_1September2013","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23918944"],"pdf_url":"http:\/\/jco.ascopubs.org\/content\/early\/2013\/08\/05\/JCO.2012.47.8313.full.pdf","pmid":"23918944","pubdate":"2013-01-01T00:00:00+00:00","publisher":"American Society of Clinical Oncology","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","type":"article","uri":"http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2012.47.8313","mendeley_url":"http:\/\/www.mendeley.com\/research\/tamoxifen-risk-contralateral-breast-cancer-ibrca1i-ibrca2i-mutation-carriers"},"altmetric_score":{"score":118.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":118.1},"context_for_score":{"all":{"total_number_of_other_articles":7383116,"mean":6.4144975994509,"rank":53337,"this_scored_higher_than_pct":99,"this_scored_higher_than":7329781,"rank_type":"exact","sample_size":7383116,"percentile":99},"similar_age_3m":{"total_number_of_other_articles":124783,"mean":6.8135704668944,"rank":1033,"this_scored_higher_than_pct":99,"this_scored_higher_than":123750,"rank_type":"exact","sample_size":124783,"percentile":99},"this_journal":{"total_number_of_other_articles":7537,"mean":12.603043259023,"rank":101,"this_scored_higher_than_pct":98,"this_scored_higher_than":7436,"rank_type":"exact","sample_size":7537,"percentile":98},"similar_age_this_journal_3m":{"total_number_of_other_articles":54,"mean":16.695320754717,"rank":2,"this_scored_higher_than_pct":96,"this_scored_higher_than":52,"rank_type":"exact","sample_size":54,"percentile":96}}},"demographics":{"poster_types":{"member_of_the_public":15,"practitioner":7,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":15,"Practitioners (doctors, other healthcare professionals)":7,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Student  > Master":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":1}}},"geo":{"twitter":{"AU":2,"ES":1,"FR":1,"US":6,"IE":1,"GB":2,"IN":1,"BE":1,"GI":1,"VE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CancerCouncilOz\/statuses\/365028228043243521","license":"public","citation_ids":[1671584],"posted_on":"2013-08-07T08:34:46+00:00","author":{"name":"Cancer Council Aust.","url":"http:\/\/www.cancer.org.au","image":"https:\/\/pbs.twimg.com\/profile_images\/1344997659\/profile_pic_normal.jpg","description":"Cancer Council Australia is the nation\u2019s peak independent cancer control body.\nFollow our CEO: @SanchiaAranda","id_on_source":"CancerCouncilOz","tweeter_id":"27996451","geo":{"lt":-25,"ln":135,"country":"AU"},"followers":25457},"tweet_id":"365028228043243521"},{"url":"http:\/\/twitter.com\/ArteSanoDeTi\/statuses\/365033233412800512","license":"public","rt":["CancerCouncilOz"],"citation_ids":[1671584],"posted_on":"2013-08-07T08:54:39+00:00","author":{"name":"ArteSanoDeTi","url":"http:\/\/t.co\/WwuSUHIrNr","image":"http:\/\/pbs.twimg.com\/profile_images\/3686564023\/424fb53fd4526384ce6d3d2fbb768164_normal.jpeg","description":"Tras el c\u00e1ncer de mi hermana (15a) decid\u00ed ayudar apoyando a j\u00f3venes con c\u00e1ncer, estoy creando una web de acompa\u00f1amiento y 1 asociaci\u00f3n.","id_on_source":"ArteSanoDeTi","tweeter_id":"1444328005","geo":{"lt":"40.4167047","ln":"-3.7035825","_id":"Madrid","country":"ES"},"followers":405},"tweet_id":"365033233412800512"},{"url":"http:\/\/twitter.com\/40JennyWilliams\/statuses\/365042547200385024","license":"public","rt":["CancerCouncilOz"],"citation_ids":[1671584],"posted_on":"2013-08-07T09:31:40+00:00","author":{"name":"Jenny Williams","image":"https:\/\/pbs.twimg.com\/profile_images\/718064195242168320\/D5jZVApH_normal.jpg","description":"Mum to Ryan Samuel and twin boys Chadrick Alexander and Charley Edward and Millie Harper, Caitlin Kate. Dallas Cowboys Fan, Lakers Fan, Breast Cancer Survivor","id_on_source":"40JennyWilliams","tweeter_id":"157044652","geo":{"lt":-33.86785,"ln":151.20732,"country":"AU"},"followers":37700},"tweet_id":"365042547200385024"},{"url":"http:\/\/twitter.com\/BCSC_research\/statuses\/364801959506616321","license":"public","citation_ids":[1671584],"posted_on":"2013-08-06T17:35:39+00:00","author":{"name":"BreastCancerSurvCons","url":"http:\/\/bcsc-research.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2656683403\/2def6202d0d1cd81f318cff465facccd_normal.jpeg","description":"Breast Cancer Surveillance Consortium research aims to improve breast cancer screening and detection, and reduce disease burden.","id_on_source":"BCSC_research","tweeter_id":"850102332","geo":{"lt":49.1,"ln":1.96667,"country":"FR"},"followers":217},"tweet_id":"364801959506616321"},{"url":"https:\/\/twitter.com\/rsm2800\/status\/366924471602384896","license":"public","citation_ids":[1671584],"posted_on":"2013-08-12T14:09:45+00:00","author":{"name":"Robert S. Miller, MD","url":"http:\/\/www.cancerlinq.org","image":"https:\/\/pbs.twimg.com\/profile_images\/768809903414710277\/RtrWPiKJ_normal.jpg","description":"Oncologist\/informaticist. Vice President and Medical Director @ASCO #CancerLinQ. My social media policy http:\/\/goo.gl\/Ey54Kf","id_on_source":"rsm2800","tweeter_id":"10989152","geo":{"lt":38.80484,"ln":-77.04692,"country":"US"},"followers":13212},"tweet_id":"366924471602384896"},{"url":"http:\/\/twitter.com\/EuropaDonnaIrel\/statuses\/367159756357906432","license":"public","citation_ids":[1671584],"posted_on":"2013-08-13T05:44:42+00:00","author":{"name":"Europa Donna Ireland","url":"http:\/\/www.europadonnaireland.ie","image":"https:\/\/pbs.twimg.com\/profile_images\/753941815133368320\/H2p0WnnQ_normal.jpg","description":"Volunteer-run breast cancer patient advocacy group. We raise awareness and campaign for equal access to best quality treatments and services.","id_on_source":"EuropaDonnaIrel","tweeter_id":"78961679","geo":{"lt":53,"ln":-8,"country":"IE"},"followers":510},"tweet_id":"367159756357906432"},{"url":"http:\/\/twitter.com\/rogersro\/statuses\/368772122941747200","license":"public","citation_ids":[1671584],"posted_on":"2013-08-17T16:31:40+00:00","author":{"name":"Ron Rogers","image":"https:\/\/pbs.twimg.com\/profile_images\/486637557430493184\/UUh8bvMe_normal.png","description":"Head of Communications at Myriad Genetics.  Posts are my opinion.  Interests are science, health, PR, cafe racers.  \r\n\r\nSalt Lake City: http:\/\/t.co\/Nca46FJ2ug","id_on_source":"rogersro","tweeter_id":"26287367","geo":{"lt":null,"ln":null},"followers":421},"tweet_id":"368772122941747200"},{"url":"http:\/\/twitter.com\/talkabouthealth\/statuses\/368773290002616322","license":"public","rt":["aftimosp"],"citation_ids":[1671584],"posted_on":"2013-08-17T16:36:18+00:00","author":{"name":"TalkAboutHealth","url":"http:\/\/www.talkabouthealth.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1243331842\/Twitter-only---TAH-circle-on-top_normal.jpg","description":"TAH is a patient education platform that collects and organizes the knowledge and expertise of the world's leading medical experts.","id_on_source":"talkabouthealth","tweeter_id":"136322338","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":24604},"tweet_id":"368773290002616322"},{"url":"http:\/\/twitter.com\/bettycjung\/statuses\/368890949197238272","license":"public","citation_ids":[1671584],"posted_on":"2013-08-18T00:23:50+00:00","author":{"name":"Betty C. Jung","url":"http:\/\/t.co\/GbkiytD6Zk","image":"http:\/\/pbs.twimg.com\/profile_images\/3721554518\/6356719fe6ebfc38dff05fa72c34abad_normal.jpeg","description":"Public Health, Health, Science & Technology. Providing you with news, information & data you can use, in real time, from Betty C. Jung MPH RN MCHES","id_on_source":"bettycjung","tweeter_id":"118788479","followers":355},"tweet_id":"368890949197238272"},{"url":"http:\/\/twitter.com\/SGSmith_87\/statuses\/370680508176662529","license":"public","rt":["aftimosp"],"citation_ids":[1671584],"posted_on":"2013-08-22T22:54:54+00:00","author":{"name":"Sam Smith","url":"http:\/\/www.researchgate.net\/profile\/Samuel_Smith6\/","image":"https:\/\/pbs.twimg.com\/profile_images\/653978115186798592\/TRCB8Hjv_normal.jpg","description":"Cancer Research UK & University Academic Fellow. Interested in cancer prevention and control","id_on_source":"SGSmith_87","tweeter_id":"635515942","geo":{"lt":53.79648,"ln":-1.54785,"country":"GB"},"followers":884},"tweet_id":"370680508176662529"},{"url":"http:\/\/twitter.com\/InOncology\/statuses\/375767861228498944","license":"datasift","citation_ids":[1671584],"posted_on":"2013-09-05T23:50:14+00:00","author":{"name":"India Oncology 2.0","url":"https:\/\/www.facebook.com\/pages\/InOncology\/149384831739338","image":"https:\/\/pbs.twimg.com\/profile_images\/1075687841\/12_normal.png","description":"The Latest in Oncology","id_on_source":"InOncology","tweeter_id":"166079744","geo":{"lt":20,"ln":77,"country":"IN"},"followers":137},"tweet_id":"375767861228498944"},{"url":"http:\/\/twitter.com\/cokelly\/statuses\/367046992330899457","license":"public","rt":["rsm2800"],"citation_ids":[1671584],"posted_on":"2013-08-12T22:16:37+00:00","author":{"name":"C. O'Kelly Priddy MD","image":"https:\/\/pbs.twimg.com\/profile_images\/891339730855636992\/j77-xQlI_normal.jpg","description":"Colleen O'Kelly Priddy, MD: Oncologic and Oncoplastic Breast Surgeon in the Southern Tier of New York; East coast transplant and snowy weather connoisseur.","id_on_source":"cokelly","tweeter_id":"70785539","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":765},"tweet_id":"367046992330899457"},{"url":"http:\/\/twitter.com\/DrMisialek\/statuses\/375066175429832704","license":"public","citation_ids":[1671584],"posted_on":"2013-09-04T01:21:59+00:00","author":{"name":"Michael Misialek, MD","url":"http:\/\/www.pathreport.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000304812609\/c5f39c9ae2fbecaab5514ab4595221ef_normal.jpeg","description":"Associate Chair of Pathology, Newton-Wellesley Hospital, Tweets about #pathology #cancer #precisionmedicine #PatientAdvocate, Tweets are not medical advice","id_on_source":"DrMisialek","tweeter_id":"1671585252","geo":{"lt":42.33704,"ln":-71.20922,"country":"US"},"followers":3985},"tweet_id":"375066175429832704"},{"url":"https:\/\/twitter.com\/PenrynPam\/status\/375066777707110400","license":"public","rt":["DrMisialek"],"citation_ids":[1671584],"posted_on":"2013-09-04T01:24:22+00:00","author":{"name":"Penryn Pam","url":"http:\/\/www.winahomeforlife.co.uk","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000059758588\/318006b9c592aa8c55f6880a711ce896_normal.jpeg","description":"Supporting #BreastCancer - Women need to feel they have a voice when going through Breast Cancer - Page not monitored daily - Enquiries @WinAHome4Life","id_on_source":"PenrynPam","tweeter_id":"1553822702","geo":{"_id":"pam@winnit.co.uk"},"followers":1110},"tweet_id":"375066777707110400"},{"url":"http:\/\/twitter.com\/aftimosp\/statuses\/368762531948412929","license":"public","citation_ids":[1671584],"posted_on":"2013-08-17T15:53:33+00:00","author":{"name":"Philippe Aftimos, MD","url":"http:\/\/be.linkedin.com\/pub\/philippe-aftimos-md\/25\/a76\/664","image":"https:\/\/pbs.twimg.com\/profile_images\/832483544064602112\/cfYg9YGh_normal.jpg","description":"Medical Oncologist and senior research physician at @JulesBordet #Brussels. Developmental therapeutics, #BreastCancer #PrecisionMedicine. Views are my own.","id_on_source":"aftimosp","tweeter_id":"177176270","geo":{"lt":50.85045,"ln":4.34878,"country":"BE"},"followers":2428},"tweet_id":"368762531948412929"},{"url":"http:\/\/twitter.com\/rogersro\/statuses\/368770444721025024","license":"datasift","citation_ids":[1671584],"posted_on":"2013-08-17T16:25:00+00:00","author":{"name":"Ron Rogers","image":"https:\/\/pbs.twimg.com\/profile_images\/486637557430493184\/UUh8bvMe_normal.png","description":"Head of Communications at Myriad Genetics.  Posts are my opinion.  Interests are science, health, PR, cafe racers.  \r\n\r\nSalt Lake City: http:\/\/t.co\/Nca46FJ2ug","id_on_source":"rogersro","tweeter_id":"26287367","geo":{"lt":null,"ln":null},"followers":421},"tweet_id":"368770444721025024"},{"url":"http:\/\/twitter.com\/PenrynPam\/statuses\/373645443412291584","license":"public","rt":["TJH0828"],"citation_ids":[1671584],"posted_on":"2013-08-31T03:16:30+00:00","author":{"name":"Penryn Pam","url":"http:\/\/www.winahomeforlife.co.uk","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000059758588\/318006b9c592aa8c55f6880a711ce896_normal.jpeg","description":"Supporting #BreastCancer - Women need to feel they have a voice when going through Breast Cancer - Page not monitored daily - Enquiries @WinAHome4Life","id_on_source":"PenrynPam","tweeter_id":"1553822702","geo":{"_id":"pam@winnit.co.uk"},"followers":1110},"tweet_id":"373645443412291584"},{"url":"http:\/\/twitter.com\/ASCO\/status\/377477550236524544","license":"public","citation_ids":[1671584],"posted_on":"2013-09-10T17:03:55+00:00","author":{"name":"ASCO","url":"http:\/\/www.asco.org","image":"https:\/\/pbs.twimg.com\/profile_images\/463779450388090880\/UsaXUpTx_normal.png","description":"ASCO is the American Society of Clinical Oncology. Making a world of difference in cancer care.","id_on_source":"ASCO","tweeter_id":"20187065","geo":{"lt":38.80484,"ln":-77.04692,"country":"US"},"followers":69114},"tweet_id":"377477550236524544"},{"url":"http:\/\/twitter.com\/BCCEU\/statuses\/367169949615538176","license":"public","rt":["europadonnairel"],"citation_ids":[1671584],"posted_on":"2013-08-13T06:25:12+00:00","author":{"name":"#BCCEU","url":"http:\/\/breastcancerchateu.wordpress.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2869382298\/85b724dfbcf1998d4aa8f475d1eb3e98_normal.jpeg","description":"Twitter chat firstThursday of each month 8.30 pm GMT for anyone with an interest in the delivery of breast cancer care across Europe.Tweets by @JBBC @audreybirt","id_on_source":"BCCEU","tweeter_id":"934311480","followers":243},"tweet_id":"367169949615538176"},{"url":"http:\/\/twitter.com\/CRWLibrary\/statuses\/365414761598431232","license":"public","citation_ids":[1671584],"posted_on":"2013-08-08T10:10:42+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"CRWLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":650},"tweet_id":"365414761598431232"},{"url":"http:\/\/twitter.com\/PharmD_Onc\/statuses\/368812533626331136","license":"public","citation_ids":[1671584],"posted_on":"2013-08-17T19:12:14+00:00","author":{"name":"Robert Kersting","url":"https:\/\/twitter.com\/#!\/PharmD_Onc","image":"https:\/\/pbs.twimg.com\/profile_images\/722546182648561665\/_HpfHsYn_normal.jpg","description":"Father, husband, triathlete, coffee addict and wanna be techie that ended up in cancer research. All tweets, posts and opinions are my own.","id_on_source":"PharmD_Onc","tweeter_id":"282672739","geo":{"lt":null,"ln":null},"followers":363},"tweet_id":"368812533626331136"},{"url":"http:\/\/twitter.com\/ugcfarmacg\/statuses\/364641826075975680","license":"public","citation_ids":[1671584],"posted_on":"2013-08-06T06:59:20+00:00","author":{"name":"UGCFarmacia Hosp. CG","image":"https:\/\/pbs.twimg.com\/profile_images\/459257567349194752\/TuuOfpsS_normal.jpeg","description":"UGC de Farmacia \u00c1rea Sanitaria Campo de Gibraltar","id_on_source":"ugcfarmacg","tweeter_id":"398654822","geo":{"lt":36.13333,"ln":-5.35,"country":"GI"},"followers":499},"tweet_id":"364641826075975680"},{"url":"http:\/\/twitter.com\/intervalolibre\/statuses\/369152433168973824","license":"public","citation_ids":[1671584],"posted_on":"2013-08-18T17:42:53+00:00","author":{"name":"Intervalolibre","url":"http:\/\/www.intervalolibre.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/898942384217739265\/Ub3BOuZE_normal.jpg","description":"Ginecolog\u00eda oncol\u00f3gica y mastolog\u00eda en tiempo libre. Gynecologic Oncology and Breast Cancer information in free time.","id_on_source":"intervalolibre","tweeter_id":"586173324","geo":{"lt":8,"ln":-66,"country":"VE"},"followers":1492},"tweet_id":"369152433168973824"},{"url":"http:\/\/twitter.com\/elizass9\/statuses\/369172285074456576","license":"public","rt":["intervalolibre"],"citation_ids":[1671584],"posted_on":"2013-08-18T19:01:46+00:00","author":{"name":"Elizabeth Spengler S","image":"https:\/\/pbs.twimg.com\/profile_images\/441750677598248960\/47JJW1Ms_normal.jpeg","id_on_source":"elizass9","tweeter_id":"39648587","geo":{"lt":null,"ln":null},"followers":301},"tweet_id":"369172285074456576"},{"url":"http:\/\/twitter.com\/TJH0828\/statuses\/373643720509235200","license":"public","citation_ids":[1671584],"posted_on":"2013-08-31T03:09:39+00:00","author":{"name":"Tina J Hieken MD","url":"http:\/\/www.mayo.edu\/research\/faculty\/hieken-tina-j-m-d\/bio-20089011","image":"https:\/\/pbs.twimg.com\/profile_images\/1803942806\/TJH_1208_md_photo_5_normal.jpg","description":"Surgical Oncologist\r\n- Opinions are mine #breastcancer #melanoma - like #data","id_on_source":"TJH0828","tweeter_id":"293182860","geo":{"lt":44.02163,"ln":-92.4699,"country":"US"},"followers":1608},"tweet_id":"373643720509235200"}],"blogs":[{"title":"Tamoxifen May Lower Breast Cancer Risk In BRCA Mutation Carriers","url":"http:\/\/www.asianscientist.com\/health-medicine\/tamoxifen-lower-breast-cancer-risk-brca-2013\/","citation_ids":[1671584],"posted_on":"2013-08-07T22:13:00+00:00","summary":"Researchers have shown that tamoxifen, a common breast cancer therapy, may reduce breast cancer risk in women who inherited BRCA mutations.","author":{"name":"Asian Scientist Magazine |  Science, Technology and Medicine News Updates From Asia","url":"http:\/\/www.asianscientist.com","description":"Science, technology, space, medicine, pharma and nature news updates from Asia & Australasia."}},{"title":"Breast cancer drug works for high-risk women","url":"http:\/\/www.futurity.org\/health-medicine\/breast-cancer-drug-works-for-high-risk-women\/","citation_ids":[1671584],"posted_on":"2013-08-08T18:54:00+00:00","summary":"U. MELBOURNE (AUS) \u2014 For women with a high risk of breast cancer, taking tamoxifen after a first tumor can dramatically reduce the chance of developing others.Tamoxifen has been used for decades to treat breast cancer and has recently been shown also to pr","author":{"name":"Futurity.org","url":"http:\/\/www.futurity.org","description":"Research news from leading universities"}}],"news":[{"title":"New role for tamoxifen in saving high-risk breast cancer patients","url":"http:\/\/ecancer.org\/news\/4294-new-role-for-tamoxifen-in-saving-high-risk-breast-cancer-patients.php","license":"public","citation_ids":[1671584,1671584,1684912,1671584],"posted_on":"2013-08-08T09:26:00+00:00","summary":"The global study was led by University of Melbourne and the Peter MacCallum Cancer Centre and published in the Journal of Clinical Oncology. The study involved about 2,500 women from Europe, North America and Australia who have inherited mutations in...","author":{"name":"ecancer","url":"http:\/\/ecancer.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/075\/normal\/image.png?1369859451"}},{"title":"New role for Tamoxifen in saving high-risk breast cancer patients","url":"http:\/\/www.healthcanal.com\/cancers\/breast-cancer\/41611-new-role-for-tamoxifen-in-saving-high-risk-breast-cancer-patients.html","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-07T09:28:00+00:00","summary":"New research has revealed women with a strong genetic predisposition to breast cancer who take the cancer prevention tablet tamoxifen after their first tumour, have a substantially reduced risk of developing a new breast cancer.","author":{"name":"Health Canal","url":"http:\/\/www.healthcanal.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/221\/normal\/image.png?1370446573"}},{"title":"Risk of Second Cancer Lower in BRCA Carriers on Tamoxifen (CME\/CE)","url":"http:\/\/www.medpagetoday.com\/HematologyOncology\/BreastCancer\/40842","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-05T22:36:10+00:00","summary":"(MedPage Today) -- Women with BRCA1 or 2 mutations had fewer contralateral breast cancers while on tamoxifen for secondary prevention, observational data showed.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}},{"title":"Tamoxifen cuts second cancer risk in BRCA carriers","url":"http:\/\/www.reuters.com\/article\/2013\/08\/16\/us-tamoxifen-cuts-second-cancer-risk-in-idUSBRE97F0OT20130816","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-16T15:47:34+00:00","summary":"NEW YORK (Reuters Health) - Taking tamoxifen is tied to a sharply reduced risk of a second breast cancer among women who carry the BRCA1 or BRCA2 \"breast cancer genes,\" new research shows.","author":{"name":"Reuters","url":"http:\/\/www.reuters.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/008\/normal\/reuters.png?1369846897"}},{"title":"New role for Tamoxifen in saving high-risk breast cancer patients","url":"http:\/\/www.sciencedaily.com\/releases\/2013\/08\/130807094646.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-07T13:46:46+00:00","summary":"New research has revealed women with a strong genetic predisposition to breast cancer who take the cancer prevention tablet Tamoxifen after their first tumor have a substantially reduced risk of developing a new breast cancer.","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}},{"title":"Study shows tamoxifen prevents breast cancers in many women","url":"http:\/\/www.news-medical.net\/news\/20130808\/Study-shows-tamoxifen-prevents-breast-cancers-in-many-women.aspx","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-08T04:46:47+00:00","summary":"The global study was led by University of Melbourne and the Peter MacCallum Cancer Centre and published in the Journal of Clinical Oncology today.","author":{"name":"The Medical News","url":"http:\/\/www.news-medical.net\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/146\/normal\/image.png?1369927508"}},{"title":"Tamoxifen for prevention in high-risk breast cancer","url":"http:\/\/www.medicalnewstoday.com\/releases\/264552.php","license":"public","citation_ids":[1671584],"posted_on":"2013-08-09T07:00:00+00:00","summary":"The global study was led by University of Melbourne and the Peter MacCallum Cancer Centre and published in the Journal of Clinical Oncology. The study involved about 2,500 women from Europe, North America and Australia who have inherited mutations in BRCA1","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"Tamoxifen cuts second cancer risk in BRCA carriers","url":"http:\/\/www.foxnews.com\/health\/2013\/08\/16\/tamoxifen-cuts-second-cancer-risk-in-brca-carriers\/","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-16T16:56:13+00:00","summary":"Taking tamoxifen is tied to a sharply reduced risk of a second breast cancer among women who carry the BRCA1 or BRCA2 \"breast cancer genes,\" new research shows.","author":{"name":"FOX News","url":"http:\/\/www.foxnews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/026\/normal\/fox_news.png?1369846915"}},{"title":"Anti-cancer drug halves risk","url":"http:\/\/www.heraldsun.com.au\/news\/victoria\/anti-cancer-drug-tamoxifen-can-halve-womens-risk-of-developing-cancer-in-second-breast-new-melbourne-research-shows\/story-fni0fit3-1226692419990","license":"public","citation_ids":[1671584,1684912],"posted_on":"2013-08-06T14:01:00+00:00","summary":"WOMEN at the highest risk of breast cancer who take anti-cancer drug Tamoxifen can halve their risk of developing cancer in the other breast, Melbourne researchers have found.","author":{"name":"Herald Sun","url":"http:\/\/www.heraldsun.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/133\/normal\/image.png?1369926556"}},{"title":"New role for Tamoxifen in saving high-risk breast cancer patients","url":"http:\/\/www.eurekalert.org\/pub_releases\/2013-08\/uom-nrf080613.php","license":"public","citation_ids":[1671584,1671584],"posted_on":"2013-08-06T04:00:00+00:00","summary":"( University of Melbourne ) New research has revealed women with a strong genetic predisposition to breast cancer who take the cancer prevention tablet Tamoxifen after their first tumor have a substantially reduced risk of developing a new breast cancer.","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"Drug offers prevention hope for women with BRCA breast cancer gene","url":"http:\/\/medicalxpress.com\/news\/2013-08-drug-women-brca-breast-cancer.html","license":"public","citation_ids":[1671584,1671584,1671584],"posted_on":"2013-08-06T16:28:09+00:00","summary":"Use of the anti-cancer drug Tamoxifen is associated with a dramatically reduced risk of developing a second breast tumour among women with a high risk gene mutation who have experienced breast cancer already, a new study has found.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"BRCA Gene No Death Knell in Long Term (CME\/CE)","url":"http:\/\/www.medpagetoday.com\/HematologyOncology\/BreastCancer\/40946","license":"public","citation_ids":[1671584,1671584,1684912,1684912],"posted_on":"2013-08-12T20:30:53+00:00","summary":"(MedPage Today) -- Women with BRCA-mutated breast cancer lived just as long as women who were not BRCA carriers, particularly mutation carriers who underwent prophylactic oophorectomy, a study of more than 3,000 breast cancer patients showed.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}}],"facebook":[{"title":"Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","url":"https:\/\/www.facebook.com\/134779230009524\/posts\/229567290530717","license":"public","citation_ids":[1671584],"posted_on":"2013-08-28T07:23:20+00:00","summary":"Tamoxifen Cuts Risk for Breast Cancer in BRCA Carriers","author":{"name":"Thai Breast Disease Society","url":"https:\/\/www.facebook.com\/134779230009524","facebook_wall_name":"Thai Breast Disease Society","image":"https:\/\/graph.facebook.com\/134779230009524\/picture","id_on_source":"134779230009524"}},{"title":"Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","url":"https:\/\/www.facebook.com\/134779230009524\/posts\/231738136980299","license":"public","citation_ids":[1671584],"posted_on":"2013-09-04T08:29:05+00:00","summary":"This study provides evidence that tamoxifen use is associated with a reduction in CBC risk for BRCA1 and BRCA2 mutation carriers. Further follow-up of these cohorts will provide increased statistical power for future prospective analyses.","author":{"name":"Thai Breast Disease Society","url":"https:\/\/www.facebook.com\/134779230009524","facebook_wall_name":"Thai Breast Disease Society","image":"https:\/\/graph.facebook.com\/134779230009524\/picture","id_on_source":"134779230009524"}}]}}